Announcements Trials

Browse Landscape

Phase

Phase 2 24 Phase 1 11 Phase 3 9 Phase 1/2 5 Phase 4 2 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Paclitaxel 9 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Cisplatin 7 Carboplatin 7 Radiotherapy, Intensity-Modulated 6 Nivolumab 6 Leucovorin 6 Filgrastim 6 Drug Therapy 6 Doxorubicin 6 Radiotherapy 5 Oxaliplatin 5 Fluorouracil 5 Docetaxel 5 Bevacizumab 5 gallium 68 PSMA-11 4 Taxes 4 Sirolimus 4 Rituximab 4 Melphalan 4 Immunoglobulin G 4 Gemcitabine 4 Disulfides 4 Dexamethasone 4 Cytarabine 4 Capecitabine 4 Calcium Dobesilate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Has results × abemaciclib × Clear all

NCT03706365 2026-04-24

CYCLONE 2

Eli Lilly and Company

Phase 2/3 Active not recruiting

393 enrolled 23 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡